FIXED ASSETS

12 Months Ended

Dec. 31, 2019

Property, Plant and Equipment [Abstract]

FIXED ASSETS

NOTE 8: FIXED ASSETS

Fixed assets at December 31, 2019 and December 31, 2018 are summarized in the table below:

Description	Useful Life (Years)		December 31,  2019			December 31, 2018
Building		30	$	3,040,000		$	3,040,000
Machinery and Equipment		3 - 7		2,437,525			2,244,744
Furniture and Fixtures		7		156,259			126,654
Automobile		5		9,500			9,395
Leasehold Improvements		7 - 15		342,330			284,037
Total Fixed Assets				5,985,614			5,704,830
Less: Accumulated Depreciation				(2,050,697	)		(1,578,049	)
Land				460,000			460,000
Construction In Progress - Equipment				7,272,499			5,281,140
Fixed Assets, net			$	11,667,416		$	9,867,921

For the years ended December 31, 2019 and 2018, depreciation expense was approximately $598,000 and $623,000, respectively.  During 2019, the additions to fixed assets of approximately $2,398,000 were primarily due to the construction of the assembly line for the Company's SYMJEPI (epinephrine) Injection 0.3 mg and 0.15 mg products, which is scheduled to be placed into service in January of 2020, and additional fixed assets purchased by USC for the relocation of the 503b operations, which are expected to be placed into service in the latter half of 2020.  The additions to fixed assets of approximately $3,941,000 during 2018 were primarily due to the USC relocation of the 503B operations into a new facility and the construction of the assembly line for SYMJEPI.  The disposals of fixed assets for the years ended December 31, 2019 and 2018 were $126,000 and $0, respectively. For the year ended December 31, 2018, the Company recorded a loss of approximately $11,000, related to the impairment of fixed assets of approximately $15,000 with accumulated depreciation of approximately $4,000.